Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
  2. Our Websites |
  3. Global Business Websites |
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce Increase  


Contact Us

sanofi-aventis (Malaysia) Sdn. Bhd. (334110-P)

Unit TB-18-1, Level 18
Tower B, Plaza 33
No.1 Jalan Kemajuan, Seksyen 13
46200 Petaling Jaya

Tel : +603 7651 0800
Fax: +603 7651 0801/2

Content :


1,000,000,000 adults across the globe suffer from cardiovascular diseases and the figures are rising. Cardiovascular diseases have become the leading cause of mortality in both the developed and the developing world.


The number of global deaths that are attributable to cardiovascular diseases alone is an astounding 30% of all causes of death (WHO Report 2004). 

Cardiovascular diseases are the leading cause of mortality in all parts of the world. The disease afflicts both the developed and the lesser developed nations of the world. It’s a disease that’s traditionally confined to the middle and older age population, but an increasing affliction of the younger age group is a disturbing trend world over. 

The prevalence of Hypertension is relatively high in Malaysia, the latest statistical data pins the figure at 33% of the adult population above 30 years old. What’s more disturbing is the fact that many of these patients are not yet been screened by the healthcare system. Many of them don’t even know that they have the disease let alone been started on any form of treatment. This percentage has been quoted to be as high as 53.2%. 

The menace of hypertension and its increasing load on our health care system has markedly worsened. The prevalence of hypertension has more than doubled between the last two national health surveys of Malaysia conducted in 1986 and 1996. The prevalence of hypertension increased from 14.3% to 33% within that period.

The treatment of cardiovascular diseases stems from the platform of life style modifications in terms of diet, exercise and modifying other known risk like alcohol and smoking. This is then coupled with medication which is a long term solution to the disease process. 

Sanofi aventis has a pioneering range of both therapeutic and preventive range of products that has been widely used in the treatment of cardiovascular diseases and hypertension.

Updated August 28, 2009

Module :